Revolutionizing Patient Care: AI and Epigenetics at the Forefront of Precision Medicine

Speakers

• 

  Jeff Bland, PhD
  

  Jeff Bland, PhD

  Jeffrey Bland, PhD, is a pioneering figure in the food-is-medicine movement and a leading expert in nutritional biochemistry. As founder of Big Bold Health, he now focuses on longevity through immune health, championing the concept of immune rejuvenation as a pathway to healthy aging. Dr. Bland’s work highlights the powerful role of plant polyphenols and omega-3 fatty acids in supporting immune resilience. Widely known as the “father of Functional Medicine,” he has spent more than 40 years advancing nutrition science, regenerative agriculture, and personalized approaches to lifelong vitality.

  Dr. Bland began his career in academia as a university professor. In the early 1980s, he became a protégé of two-time Nobel Laureate, Dr. Linus Pauling. Dr. Bland then spent decades as a natural products industry insider and entrepreneur, while also serving as a scientific advisor and mentor to dynamic founders and leading brands.

  A lifelong educator, Dr. Bland has traveled the world many times over as a renowned speaker. In 1991, he and his wife, Susan, founded The Institute for Functional Medicine. In 2012, they established another educational nonprofit called The Personalized Lifestyle Medicine Institute, which brings together researchers, clinicians, industry leaders, and other stakeholders to focus on new models of healthcare delivery, advancements in medical nutrition therapy, and exciting emerging science.

  Dr. Bland is the author of The Disease Delusion: Conquering the Causes of Chronic Illness for a Healthier, Longer, and Happier Life, as well as additional books and many research papers. His next book will be published by HarperCollins in March 2027. The Nourished Gene: Rejuvenate Your Immunity, Reverse Chronic Symptoms, and Activate Your Longevity is now available for pre-order from all major booksellers.

• 

  Ryan Smith
  

  Ryan Smith

  Ryan Smith is founder of TruDiagnsotic. Ryan received a BA in Biochemistry from Transylvania University before heading to medical school in 2013. After passing USMLE Step 1, he decided to leave and open up a pharmacy in the United States that focused on peptide synthesis and formulations for pharmaceutical preparations. That pharmacy, Tailor Made Compounding, became the 4th fastest growing company in healthcare in the US and grw to 80 million in revenue within 3 years. Through this pharmacy work, Ryan saw the value of preventative medicine. Many of the physicians Tailor Made served were treating age as a disease and a primary outcome but needed better tools to measure this process. As a result, Ryan exited Tailor Made in 2020 to create TruDiagnostic.

  TruDiagnostic is a CLIA certified lab and health data company which specializes in understanding and reporting insights found through Epigenetic methylation data. Since starting in 2020, TruDiagnostic has created the largest private epigenetic database in the world with over 15,000 patients tested on the EPIC850k array. From this dataset, they have created many new algorithms to interpret methylation data including algorithms to predict inflammatory markers, disease diagnosis, telomere length, aging pace, immune cell subsets, cellular replication, and more. TruDiagnostics has also led research in the field with over 30+ clinical trials investigating the best ways to reverse these markers through diet, lifestyle, and prescription interventions. Currently, TruDiagnostic is working with collaborators from Duke, Harvard, Yale, UCSF, Ohio St. and more to uncover new insights from the methylome. TruDiagnostic is also the only commercial company on the market to offer 2nd or 3rd generation aging algorithms which have shown to be more predictive and precise than 1st generation aging clocks.

  In addition to his work with pharmaceuticals, Ryan also consults with international pharmacies and has set up pharmacies in Thailand and Mexico. In addition, Ryan has developed novel supplements and cosmetic formulations with multiple 100M supplement brands and consults with clinics in the cash pay wellness space.

• 

  Matthew Dawson, MD
  

  Matthew Dawson, MD

  Dr. Matthew Dawson, a leading innovator in the field of epigenetics, is dedicated to bridging cutting-edge genomic science with practical healthcare applications. After earning his medical degree from the University of Kentucky and completing an emergency medicine residency at the University of Utah, where he served as chief resident, Dr. Dawson practiced and taught at the University of Kentucky as an associate professor for seven years. His interest in genomics and epigenetics deepened as he recognized their potential to revolutionize how we understand aging, disease prevention, and human health.
   
   
  As CEO of TruDiagnostic, Dr. Dawson oversees a groundbreaking mission to unlock the potential of epigenetic data, empowering individuals and researchers alike to make informed decisions about healthspan and longevity. Under his leadership, TruDiagnostic has become a leader in epigenetic testing and biological aging research, leveraging advanced DNA methylation technology to provide actionable insights into personal health and disease risk.
    
   
  A passionate advocate for health optimization, Dr. Dawson’s expertise extends beyond traditional medicine, encompassing fitness, nutrition, and biohacking. He is a sought-after speaker, recently contributing to prestigious platforms such as the Personalized Lifestyle Medicine Institute (PLMI), where he is spearheading the integration of Epigenetic Biomarkers (EBPs) and Methylation Risk Scores (MRS) into preventive healthcare strategies. Dr. Dawson’s vision for TruDiagnostic focuses on making this emerging science accessible to both clinicians and the general public, driving a future where personalized health interventions are guided by precise epigenetic data.